Tag:
R&D
Latest Headlines
Latest Headlines
UPDATED: Sangart stashes $50M funding for oxygenation drugs
The seventh-round financing is expected to fuel development of San Diego-based Sangart's treatments that deliver essential gases to embattled tissues.
Upstart biotech lures Vertex founder out of retirement
Alkeus and their lead program have hooked Josh Boger, who has decided to step back out of retirement to act as executive chairman for the fledgling Boston-based company after making a small investment.
Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement
Based on the findings published in Quintiles' annual "New Health Report," payers want to get the ball rolling sooner to get drugs approved faster.
Flowonix Medical grabs $25M for implantable drug pump
Flowonix Medical, formally known as Medasys, drew in $25 million in fresh investment that the company will use to bring its Prometra implantable drug delivery pump to market.
Pharma giants join forces on $285M antibiotics collaboration
GlaxoSmithKline, Sanofi, AstraZeneca, J&J as well as Basilea will join an R&D consortium including Europe's Innovative Medicines Initiative to fund the effort, setting up an information hub that will share data among investigators laboring on new antibiotics.
HIV vaccine carries its own adjuvant into clinical trials
The trial will include 48 people at four sites in the U.S., 40 receiving the vaccine at increasing doses and 8 as controls, and will check the safety of the vaccine while looking out for an immune response.
DNA vaccine swats TB and HIV
TB is the leading cause of death among people with HIV infection, and being able to give people a shot that treats HIV and protects against TB would be a major breakthrough for this vulnerable group of people.
Army uses ducks and DNA vax to make antivirals
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and its collaborators have created a route to producing an antibody-based treatment using a DNA vaccine and duck eggs.
Purdue U., U.S. Army explore nanotech-coated stent to combat brain aneurysms
Purdue University scientists are studying whether stents coated with a nanotechnology-enhanced drug could serve as potent treatment for aneurisms. And a lead researchert involved in the effort will speak before Congress on May 24 to talk about how nanotechnology could help treat brain injury and disease.
Boehringer gets positive PhII for COPD inhalant
Boehringer Ingelheim is touting positive Phase II results for a new COPD treatment using its Respimat inhaler.
